Managing Editor
@ShahidNShah
@ShahidNShah
The Effects of mHealth Interventions on Quality of Life, Anxiety, and Depression in Patients With Coronary Heart Disease: Meta-Analysis of Randomized Controlled Trials
Coronary heart disease (CHD) is the leading cause of death globally. In addition, 20% to 40% of the patients with CHD have comorbid mental health issues such as anxiety or depression, affecting the prognosis and quality of life (QoL). Mobile health (mHealth) interventions have been developed and are widely used; however, the evidence for the effects of mHealth interventions on QoL, anxiety, and depression in patients with CHD is currently ambiguous.
Medigy Insights
Mobile health (mHealth) interventions—such as apps and remote monitoring—can significantly improve quality of life and reduce anxiety and depression in patients with coronary heart disease, especially with long-term use.
Continue reading at jmir.org
Make faster decisions with community advice
- AI-Supported Shared Decision-Making (AI-SDM): Conceptual Framework
- An LLM Chatbot To Facilitate Primary-To-Specialist Care Transitions: A Randomized Controlled Trial
- Bias-Mitigated AI as a Foundation for Resilient and Effective Health Systems
- Challenges of Telemonitoring Programs for Complex Chronic Conditions: Randomized Controlled Trial With an Embedded Qualitative Study
- Considerations for Establishment of a Private Virtual Hospital Identified Using an Implementation Science Approach
Next Article
-
Facilitated Telemedicine as a Patient-Centered, Sociotechnical Intervention to Integrate Hepatitis C Treatment Into Opioid Treatment Programs and Overcome the Digital Divide Among Underserved Populations: Qualitative Study
People with opioid use disorder (OUD) have the highest rates of hepatitis C virus (HCV) infection. Despite the availability of curative HCV medication, people with OUD have limited health care access …
